BioPhenyx ApS: Financial statements 2025
CVR: 42954810
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
BioPhenyx ApS (CVR 42954810) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 5,532 and a net result of DKK -7,280 compared with DKK -270,452 the year before. Equity in the 2025 report amounted to DKK -191,630.
- Gross Profit
- DKK 5,532
- Profit/Loss
- DKK -7,280
- Equity
- DKK -191,630
- Total Assets
- DKK 11,771
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 6 t. | -7 t. | -192 t. | 0 |
| 2024 | - | -269 t. | -270 t. | -184 t. | - |
Official annual report
How creditworthy is BioPhenyx ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of December 29, 2025, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has stepped down as auditor of BioPhenyx ApS.
About BioPhenyx ApS
BioPhenyx ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Casper Carstens Lund, Morten Frödin and Ole Bitsch-Jensen. The company is owned by Phenyx Holding ApS. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK 112,870 and a net result of DKK 101,721 compared with DKK -7,280 the year before. Equity in the 2026 report amounted to DKK -89,909.